Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer – PR Newswire (press release)
Medical Daily |
Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer
PR Newswire (press release) NEW YORK, June 3, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug pembrolizumab—already FDA-approved for other forms of cancer–has been found to be effective in patients with metastatic triple negative breast cancer, according to an … Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily |
Oncology Nurse Advisor |
Stem Cell Transplant Patients Benefit From Inpatient Palliative Care
Oncology Nurse Advisor CHICAGO — Inpatient palliative care integrated with hematopoietic stem cell transplantation (HSCT) care is associated with improvements in depression and symptoms of post-traumatic stress disorder (PTSD) at 6 months after transplantation … |
STAT |
U.S. could save $825 million a year with a small change in immunotherapy dosing, study says
STAT That’s the finding of a new study on the immunotherapy drug pembrolizumab, marketed commercially as Keytruda by Merck. By switching to weight-based dosing — instead of a fixed dose of 200 mg — doctors could quickly reduce costs of the intravenous … |
Wall Street Pit |
CRISPR Found To Have A Dangerous Side-Effect: Unwanted Mutations
Wall Street Pit People have been calling the CRISPR gene editing technology revolutionary for good reason: there’s no doubt that if used properly, it has the potential to cure many of the world’s worst diseases and medical disorders. And yet the fear that it can be … Unexpected mutations after CRISPR gene-editingBioEdge |
WOAI |
MS patients await governor’s signature on bill allowing adult stem cell therapy
WOAI Cowley said Celltex in Houston does a mini-liposuction, extracting a few tablespoons of her fan, then prepares the hundreds of millions of stem cells. She has traveled to Cancun several times so a private hospital there can set up an hour-long IV to … |